Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course
Implications for early discharge after coronary intervention
Annapoorna Kini, MDa,
Jonathan D. Marmur, MD, FACCa,
Subhash Kini, MDa,
George Dangas, MDa,
Thomas P. Cocke, MD, FACCa,
Sylvan Wallenstein, PhDa,
Eppie Brown, RNa,
John A. Ambrose, MD, FACCa and
Samin K. Sharma, MD, FACCa
a Cardiac Catheterization Laboratory of the Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USA
View larger version (25K):
[in a new window]
|
Figure 1 CK-MB elevation in relation to single- or multivessel intervention.
|
|
View larger version (8K):
[in a new window]
|
Figure 2 CK-MB elevation in relation to ACC/AHA lesion type.
|
|
View larger version (26K):
[in a new window]
|
Figure 3 CK-MB elevation in relation to diffuse or focal coronary disease.
|
|
View larger version (24K):
[in a new window]
|
Figure 4 CK-MB elevation in relation to interventional device type. *p = 0.01 for PTCA vs. non-balloon devices; **p = 0.07 for PRCA only vs. stent only.
|
|
|
